about
Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsAntipsychotic medications for cocaine dependenceQ24197685Antipsychotic medications for cocaine dependenceKappa opioids as potential treatments for stimulant dependenceHedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapiesPharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addictionQuinine enhances the behavioral stimulant effect of cocaine in mice.Monoamine transporter inhibitors and substrates as treatments for stimulant abuseSubstance Use Attenuates Physiological Responses Associated With PTSD among Individuals with Co-Morbid PTSD and SUDs.Cocaine users manifest impaired prosodic and cross-modal emotion processing.Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence.Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain.Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats.Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction.Is slow-onset long-acting monoamine transport blockade to cocaine as methadone is to heroin? Implication for anti-addiction medications.Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.Dopamine transporter levels in cocaine dependent subjects.Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanismThe novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuseHypothesis-driven medication discovery for the treatment of psychostimulant addictionLarge-Scale, Ion-Current-Based Proteomic Investigation of the Rat Striatal Proteome in a Model of Short- and Long-Term Cocaine Withdrawal.Imidazoline receptor antisera-selected/Nischarin regulates the effect of agmatine on the development of morphine dependence.Impaired emotional empathy and related social network deficits in cocaine users.Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context.Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior.Two new neurophysiological indices of cocaine craving: evoked brain potentials and cue modulated startle reflex.Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation.CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.Motor-skill learning-associated gene regulation in the striatum: effects of cocaine.Cocaine increases dopaminergic connectivity in the nucleus accumbens.Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction.Abuse potential and adverse cognitive effects of mitragynine (kratom).
P2860
Q22251215-9D376E3D-2B96-4DFF-888F-3E21BD7635A5Q24186021-B3E7B05C-49A4-4E51-BB0C-DA74B19E33FCQ24197685-C89EB3B0-3E65-4ECD-AA90-9B8D54E348A3Q24243837-B85E3725-6A4B-4391-BA92-BB721E3F9FFDQ24647849-6F832E09-887C-47C5-9F91-D111643B9466Q24672819-62AF2AEA-AEFC-4C16-8BF2-C4CE17306F63Q28236375-C5697545-D7A4-4D9D-A3EC-9CA77AAEF33CQ30392526-09827F86-2DDF-4BA7-9010-3E2C9BEB0850Q30413718-90C41136-2409-4134-A264-3C773271536AQ30444772-14282A33-6BD4-4BF4-A633-27E6A6BB0D8EQ30449233-965891B5-C663-4E9F-B09D-54683C030E7FQ30450348-1B9DCEA5-62E3-48E7-AF89-743CBD8A05E9Q31406604-E53A99CF-A9D6-43B8-B79B-046DB55D32E8Q33895929-7309BE81-1FB5-45D2-989A-A4A2A2525D04Q34086076-317F04C5-6256-4739-936D-C946B9EE1F5EQ34136977-73E746EE-379C-4EA6-AC57-93396A6F0236Q34247763-A1650AA5-DD95-4203-8482-3241DE818C5CQ34438529-FB86A02F-AF5D-4BB8-BF54-EE442282B19FQ36930260-C0413266-DC41-4511-BD1C-826FB568B8B3Q36952331-4D81D936-FFCA-49B7-9BFA-DB4F30132DDBQ37169002-3E8DD5DD-CD01-454E-B389-F137F1F148BAQ37183687-DA657120-DB1F-4530-8E2C-0B32573656C8Q39885945-C66699A5-86DB-4057-9E0C-706CA973A1F8Q42495434-20919E3C-4CCA-4D05-9332-A801B4EA56B4Q42710525-FB49FC31-A830-476A-8C1C-BFA61FE535E9Q42914137-87A175FD-A2BA-40C6-A9B2-32E7EB11F0BDQ44150342-A485B38C-16D2-4BB0-AD41-F95338FDBD0CQ44373754-8A1E3AB6-452A-40B1-9C28-6582EE635DC0Q44423347-55AC2937-1B01-4667-BDD2-B76E8046B906Q45176534-E61F1540-86F9-465C-B97C-CE5754225323Q45258415-2734F709-E85D-4CBC-8FDB-689A2290BB19Q46043227-66172C27-2101-4345-812C-321AA4DA4575Q46881179-E1F682DE-EACF-4C9F-ADDE-5D729ED82332Q47598515-475E2166-EC57-495C-9833-E20B8BB33CADQ48482211-6F08BFEF-F9B5-4A8B-AAF4-7930554E5945Q50631913-9315D255-4B57-470A-A72A-86159CE50295
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Neurochemical changes in cocaine withdrawal.
@en
type
label
Neurochemical changes in cocaine withdrawal.
@en
prefLabel
Neurochemical changes in cocaine withdrawal.
@en
P1476
Neurochemical changes in cocaine withdrawal.
@en
P2093
P304
P356
10.1016/0165-6147(96)10024-9
P577
1996-07-01T00:00:00Z